The Majewski family remains hopeful for their four-year-old son Max, who has a rare neurological disorder, as they seek ...

To reset the laboratory space to an operational environment, TOMI’s iHP Corporate Service team will perform a comprehensive whole-facility fogging service. This service covers all critical areas, ...

RheumaGen will use the funds to advance its therapeutic development program in celiac disease through preclinical proof of concept.

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

The region helped invent cell and gene therapy. Now, there’s an opportunity to reengineer it so more people can actually access it, a life sciences leader writes.

A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.

At the Cleveland Clinic, doctors are using a one-time gene-editing therapy that alters a patient’s own blood-forming stem cells to correct the genetic mutation responsible for the disease. Physicians ...

T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic, B7-H3-targeted CAR-T therapy, MT027, has received IND Clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase ...

In the past three years, gene therapy has reshaped what's possible in hemophilia treatment for patients 18 and older. But a ...

The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead of Christmas. KJ Muldoon is walking and getting ready to celebrate ...

JABSOM Cell and Molecular Biology researcher Dr. Jesse Owens has spent the better part of two decades chasing a vision that ...

Backed by a handful of prominent investors including the Gates Foundation, the startup is pursuing an approach it believes ...